Basic clinical and Laboratory features of filoviral hemorrhagic fever

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 3, 2011, Pages

  Kortepeter, Mark G ^a   Bausch, Daniel G ^b   Bray, Mike ^c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b TULANE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; BLEEDING TIME; CENTRAL AFRICA; CLINICAL FEATURE; CLINICAL RESEARCH; CLINICAL STUDY; DRUG ERUPTION; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; EPIDEMIC; FEVER; FILOVIRUS INFECTION; HUMAN; INDUSTRIALIZATION; LABORATORY INFECTION; LABORATORY TEST; LEUKOPENIA; MARBURG HEMORRHAGIC FEVER; MARBURG VIRUS; MEDICAL PERSONNEL; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTOPENIA;

ANIMALS; BLOOD CELL COUNT; BLOOD COAGULATION; BLOOD PRESSURE; DERMATITIS; FEVER; HEMATOCRIT; HEMOGLOBINS; HEMORRHAGE; HEMORRHAGIC FEVER, EBOLA; HUMANS; MARBURG VIRUS DISEASE;

EID: 80054741233     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir299     Document Type: Article

References (54)

1. Leroy EM, Epelboin A, Mondonge V, et al. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis 2009; 9:723-8.
2. Hartman AL, Towner JS, Nichol ST. Ebola and Marburg hemorrhagic fever. Clin Lab Med 2010; 30:161-77.
3. Martini GA. Marburg virus disease. Clinical syndrome. In: Martini GA, Siegert R, eds. Marburg virus disease. New York: Springer Verlag, 1971; 1-9.
4. Egbring R, Slenczka W, Baltzer G. Clinical manifestations and mechanism of the haemorrhagic diathesis in Marburg virus disease. In: Martini GA, Siegert R, eds. Marburg virus disease. New York: Springer Verlag, 1971; 41-9.
5. Stille W, Boehle E. Clinical course and prognosis of Marburg virus ("green monkey") disease. In: Martini GA, Siegert R, eds. Marburg virus disease. New York: Springer Verlag, 1971; 10-8.
6. Gedigk P, Bechtelsheimer H, Korb G. Pathologic anatomy of the Marburg virus disease. In: Martini GA, Siegert R, eds. Marburg virus disease. New York: Springer Verlag, 1971; 50-63.
7. Havemann K, Schmidt HA. Haematological findings in Marburg virus disease. In: Martini GA, Siegert R, eds. Marburg virus disease. New York: Springer Verlag, 1971; 34-40.
8. Dietrich M, Schumacher HH, Peters D, Knobloch J. Human pathology of Ebola (Maridi) virus infection in the Sudan. In: Pattyn S, ed. Ebola virus haemorrhagic fever. Amsterdam: Elsevier, 1978; 37-9.
9. Todorovitch K, Mocitch M, Klasnja R. Clinical picture of two patients infected by the Marburg vervet virus. In: Martini GA, Siegert R, eds. Marburg virus disease. New York: Springer Verlag, 1971; 19-23.
10. Gear JS, Cassel GA, Gear AJ, et al. Outbreak of Marburg virus disease in Johannesburg. Br Med J 1975; 4:489-93.
11. Smith DH, Johnson BK, Isaacson M, et al. Marburg-virus disease in Kenya. Lancet 1982; 1:816-20. (Pubitemid 12133655)
12. Nikiforov VV, Turovskii Iu I, Kalinin PP, et al. A. case of a laboratory infection with Marburg fever [in Russian]. Zh Mikrobiol Epidemiol Immunobiol 1994: 3:104-6.
13. Colebunders R, Tshomba A, Van Kerkhove MD, et al. Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment. J Infect Dis 2007; 196(Suppl 2):S148-53. (Pubitemid 351417254)
14. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 2006; 355:909-19. (Pubitemid 44315983)
15. Timen A, Koopmans MP, Vossen AC, et al. Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis 2009; 15:1171-5.
16. CDC. Imported case of Marburg hemorrhagic fever-Colorado, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:1377-81.
17. Piot P, Bureau P, Breman J, et al. Clinical aspects of Ebola virus infection in Yambuku area, Zaire, 1976. In: Pattyn S, ed. Ebola virus haemorrhagic fever. Amsterdam: Elsevier, 1978; 17-21.
18. Isaacson M, Sureau PH, Courteille G, Pattyn SR. Clinical aspects of Ebola virus disease at the Ngaliema hospital, Kinshasa, Zaire, 1976. In: Pattyn S, ed. Ebola virus haemorrhagic fever. Amsterdam: Elsevier, 1978; 22-6.
19. Sureau PH. Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire. Rev Infect Dis 1989; 11(Suppl 4):S790-3.
20. WHOZaire. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978; 56:271-93.
21. Murphy FA. Pathology of Ebola virus infection. In: Pattyn S, ed. Ebola virus haemorrhagic fever. Amsterdam: Elsevier, 1978; 39-53.
22. Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, Berquist H. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis 1980; 142:372-6. (Pubitemid 10024573)
23. Bonnet MJ, Akamituna P, Mazaya A. Unrecognized Ebola hemorrhagic fever at Mosango hospital during the 1995 epidemic in Kikwit, Democratic Republic of the Congo. Emerg Infect Dis 1998; 4:508-10. (Pubitemid 28387452)
24. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999; 179(Suppl 1):S1-7. (Pubitemid 29091373)
25. Ndambi R, Akamituna P, Bonnet MJ, Tukadila AM, Muyembe- Tamfum JJ, Colebunders R. Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(Suppl 1):S8-10.
26. Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 1999; 179(Suppl 1):S28-35. (Pubitemid 29091380)
27. Ksiazek TG, Rollin PE, Williams AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(Suppl 1):S177-87. (Pubitemid 29091400)
28. Richards GA, Murphy S, Jobson R, et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med 2000; 28:240-4. (Pubitemid 30091061)
29. Baize S, Leroy EM, Georges-Courbot MC, et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999; 5:423-6. (Pubitemid 29180581)
30. Georges-Courbot MC, Lu CY, Lansoud-Soukate J, Leroy E, Baize S. Isolation and partial molecular characterisation of a strain of Ebola virus during a recent epidemic of viral haemorrhagic fever in Gabon. Lancet 1997; 349:181. (Pubitemid 27039207)
31. Baize S, Leroy EM, Georges AJ, et al. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 2002; 128:163-8. (Pubitemid 34451194)
32. Akinfeeva LA, Aksionova OI, Vasilevich IV, et al. A case of Ebola hemorrhagic fever [in Russian]. Infektsionnie Bolezni 2005; 3:85-8.
33. Smith DH, Francis DP, Simpson DIH. African haemorrhagic fever in the southern Sudan, 1976: the clinical manifestations. In: Pattyn S ed. Ebola virus haemorrhagic fever. Amsterdam: Elsevier, 1978; 27-30.
34. WHO Sudan. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ 1978; 56:247-70.
35. Emond RT, Evans B, Bowen ET, Lloyd G. A case of Ebola virus infection. Br Med J 1977; 2:541-4. (Pubitemid 8160914)
36. Sanchez A, Lukwiya M, Bausch D, et al. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 2004; 78:10370-7. (Pubitemid 39258362)
37. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004; 78:4330-41. (Pubitemid 38437236)
38. Rollin PE, Bausch DG, Sanchez A. Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis 2007; 196(Suppl 2):S364-71. (Pubitemid 351417283)
39. Formenty P, Hatz C, Le Guenno B, Stoll A, Rogenmoser P, Widmer A. Human infection due to Ebola virus, subtype Cote d'Ivoire: clinical and biologic presentation. J Infect Dis 1999; 179(Suppl 1):S48-53. (Pubitemid 29091382)
40. MacNeil A, Farnon E, Wamala J, et al. Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis 2010;16:1969-72.
41. Wamala JF, Lukwago L, Malimbo M, et al. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. Emerg Infect Dis 2010; 16:1087-92.
42. Martini GA, Siegert R. Marburg virus disease. New York: Springer Verlag, 1971.
43. Pattyn S ed. Ebola virus haemorrhagic fever. Amsterdam: Elsevier, 1978.
44. Kuhn JH. Filoviruses: a compendium of 40 years of epidemiological, clinical and laboratory studies. New York: Springer Wien, 2008.
45. Leroy EM, Baize S, Volchkov VE, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000; 355:2210-5. (Pubitemid 30394329)
46. Sadek RF, Khan AS, Stevens G, Peters CJ, Ksiazek TG. Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis 1999; 179(Suppl 1):S24-7.
47. Zaki SR, Goldsmith CS. Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol 1999; 235:97-116.
48. Wauquier N, Becquart P, Gasquet C, Leroy EM. Immunoglobulin G in Ebola outbreak survivors, Gabon Emerg Infect Dis 2009; 15:1136-7.
49. Bausch DG, Feldmann H, Geisbert TW, et al. Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient. J Infect Dis 2007; 196(Suppl 2):S136-41. (Pubitemid 351417252)
50. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007; 196(Suppl 2):S142-7. (Pubitemid 351417253)
51. Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003; 163:2347-70. (Pubitemid 37466478)
52. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/ macrophages is a key event. J Infect Dis 2003; 188:1618-29. (Pubitemid 38010671)
53. Geisbert TW, Young HA, Jahrling PB, et al. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 2003; 163:2371-82. (Pubitemid 37474154)
54. Kortepeter M, Honko A, Johnson JC, et al. Real-time monitoring of cardiovascular function in rhesus macaques infected with Zaire ebolavirus. Journal of Infectious Diseases 2011; doi: 10.1093/infdis/jir337.